In this video, we explain the capstan equation and how friction affects a rope or string wrapped around a surface. You’ll learn where the equation comes from, what each term means, and how it’s ...

SANTA CRUZ, Calif., Jan. 7, 2026 /PRNewswire/ -- Capstan Medical, a developer of robotic-enabled, minimally invasive solutions to address heart valve disease, today announced the appointment of ...

Google's latest addition to its NotebookLM artificial intelligence research platform is a feature called Data Tables. The tool can collect and synthesize information across multiple sources into a ...

Low-to-the-ground styles to hold in high esteem, no matter the price point. By Tom Delavan In T’s column 1 Piece, 10 Budgets, we share 10 perfect versions of an item in a range of prices. This time, ...

Arcturus Therapeutics sued AbbVie and Capstan Therapeutics for allegedly misusing its lipid nanoparticle (LNP) delivery technology after former staff joined Capstan. The case spotlights the high ...

AbbVie, Capstan Therapeutics and other defendants were hit with a trade secret lawsuit on Sept. 23 in California Southern District Court. The suit, filed by Wilson Sonsini Goodrich & Rosati on behalf ...

Sept 23 (Reuters) - Biotech company Arcturus Therapeutics (ARCT.O), opens new tab sued AbbVie (ABBV.N), opens new tab in California federal court on Tuesday for allegedly stealing trade secrets ...

Google Tables, a work-tracking tool and competitor to the popular spreadsheet-database hybrid Airtable, is shutting down. In an email sent to Tables users this week, Google said the app will not be ...

(RTTNews) - AbbVie (ABBV) has completed its acquisition of Capstan Therapeutics, bringing the biotech company under its umbrella. Capstan's lead program, CPTX2309, is a Phase 1 tLNP-based therapy that ...

Acquisition adds a potential first-in-class in vivo targeted lipid nanoparticle (tLNP) anti-CD19 CAR-T therapy candidate for B cell-mediated autoimmune diseases as well as a proprietary tLNP platform ...

Capstan Therapeutics — a biotechnology company pioneered by Penn researchers — was acquired by AbbVie in $2.1 billion deal. Capstan, which specializes in CAR-T therapies for autoimmune disorders, ...

AbbVie ABBV announced that it has entered into a definitive agreement to acquire privately held biotech, Capstan Therapeutics, for up to $2.1 billion in cash. The impending acquisition will add ...